Numbers first: a GLP-1 receptor agonist · 2.5 mg/mL.
I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.
Assume no laboratory access beyond what I can pay a third party for.
Concretely, what should I do, and how would I know afterwards whether I did it right?
Nobody has published a cycle count, and at 2.5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.25 mg and every microlitre is 2.5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 2.5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 2.5 mg/mL and the date, and never thaw a container you will refreeze.
Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.
During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.
| Pathway | Dominant when | Detected by |
|---|---|---|
| Deamidation | Solution, neutral to alkaline pH | RP-HPLC, +1 Da on MS |
| Oxidation | Light, trace metals, peroxides | RP-HPLC, +16 Da on MS |
| Hydrolysis | Solution, extremes of pH | RP-HPLC, fragment masses |
| Aggregation | Agitation, interfaces, high concentration | SEC, visual haze; often invisible on RP-HPLC |
| Freeze-concentration damage | Freeze-thaw of buffered solution | SEC, loss of recovered content |
The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.
Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.
The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.
Dry powder tolerates cycles far better than solution does.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsStart with how many cycles are actually planned, because one or two are immaterial and ten are not.
Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.
Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.
Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.
Aliquoting itself is a handling step and introduces its own contamination opportunity.
Count cycles, not degrees. The cycle is the damaging event.
The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.
Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.
Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.
The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.
Thaw slowly and never refreeze an aliquot.
edited 11 Jul 2024 by orla_sheridan — added a caveat about sampling
The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.
Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Let a frozen vial reach room temperature before opening, or you condense water into it.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.